Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

about

Emergent presentation of decompensated mitral valve prolapse and atrial septal defect.Outcomes after mitral valve surgery for rheumatic heart disease.

P2860

Q35592740-4A33CFE9-0EE1-42FF-AD8F-DBCECA86C9D4 Q55119746-356246E2-9B50-4ECC-9082-55E55F42EB7A

P2860

Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

Item

http://www.wikidata.org/entity/Q38191659

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

@en

type

Item

label

Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

@en

prefLabel

Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

@en

P1476

Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

@en

P2093

Nalini M Rajamannan

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the

A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4.

Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation.

Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve

The role of Lrp5/6 in cardiac valve disease: experimental hypercholesterolemia in the ApoE-/- /Lrp5-/- mice.

Parameters of LRP5 from a structural and molecular perspective.

The role of Lrp5/6 in cardiac valve disease: LDL-density-pressure theory.

Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.

Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway.

Aortic sclerosis and mitral annulus calcification: a window to vascular atherosclerosis?

P304

383-392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2014.893191

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24575776

http://www.w3.org/2001/XMLSchema#string

P932

4048944

http://www.w3.org/2001/XMLSchema#string

Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

about

P2860

P2860

Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932